Melinda Maggard‐Gibbons
University of California, Los Angeles, Olive View-UCLA Medical Center, RAND Corporation, American College of Surgeons
Papers
10
Total Citations
557
H-Index
8
About
Melinda Maggard-Gibbons is a leading health services researcher and surgeon whose work has fundamentally shaped our understanding of robotic surgery’s real-world value. Her research focuses on the comparative effectiveness, clinical outcomes, and economic implications of robotic-assisted procedures across general surgery. She is best known for her landmark 2018 study, cited over 250 times, which established the first rigorous benchmark for the acquisition and operating costs of robotic surgery platforms—a critical tool for future cost-effectiveness evaluations. Maggard-Gibbons has also led major systematic reviews comparing robotic, laparoscopic, and open approaches for esophageal cancer, cholecystectomy, ventral hernia repair, and partial nephrectomy, collectively cited hundreds of times. Notably, she has investigated the influence of corporate payments on robotic surgery research, bringing much-needed transparency to conflicts of interest in the field. Her work at the Veterans Health Administration has provided unique insights into the adoption and outcomes of robotic procedures in a large, integrated healthcare system. Through her rigorous, evidence-based analyses, Maggard-Gibbons has become an indispensable voice guiding surgeons, hospitals, and policymakers in decisions about the adoption and use of robotic technology.
Research Focus
Key Achievements
Top Papers
- 1Estimation of the Acquisition and Operating Costs for Robotic Surgery257 citations · 2018
- 2
- 3
- 4
- 5The Impact of Corporate Payments on Robotic Surgery Research35 citations · 2018
- 6
- 7Trends in the use of robotic-assisted surgery during the COVID 19 pandemic15 citations · 2021
- 8
- 9
- 10